Feel Therapeutics
AI-enabled Digital Precision Medicine to reinvent the way we diagnose, manage, and care for Mental Health
Founded 2015 · $18.2M raised
- Founded
- 2015
- Website
- myfeel.co
- Total Funding
- $18.2M
- Last Round
- $7.9M Venture RoundApr 2025
- Rounds
- 4
About
Feel Therapeutics is a Digital Precision Medicine company that brings continuous and passive physiological monitoring into the field of mental healthcare. Its AI-powered platform collects data 24/7 from wearables, digital health apps, and mobile devices to generate objective physiological and digital biomarkers for mental health conditions including depression, anxiety, ADHD, stress, and insomnia. The company offers three core solutions: Feel 360 for clinical trials and real-world studies, Feel RxPal for improving patient adherence and engagement, and Feel DTx for precision digital therapeutics. Partners include Johnson & Johnson, Janssen, Bayer, Biogen, and SCOR, with published clinical outcomes in Nature Digital Medicine.
Summary
Feel Therapeutics is a company, founded in 2015. It has raised $18.2M in total across 4 rounds, most recently a $7.9M Venture Round round in Apr 2025.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Apr 2025
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.